Lan Li1, Tao YU1, ShiXi Jiang1, YouXi Yuan1, JiuQuan Zhang1, and Jianqing SUN2
1Chongqing University Cancer Hospital & Chongqing Cancer Institute & Chongqing Cancer Hospital, ChongQing, China, 2Philips Healthcare, Shanghai, China
Synopsis
To establish a radiomic model based on
dynamic contrast enhanced (DCE) magnetic resonance imaging predicting ALN
status noninvasively before operation.
Background
The status of axillary lymph node (ALN) is
closely related to the prognosis of the patients with breast cancer, and
determines the mode of surgery and the formulation of adjuvant treatment [1,2]. ALN
status is currently determined by invasive SLN biopsy in clinical practice.Methods
In this retrospective research, we
collected 197 patients who underwent breast magnetic resonance dynamic
enhancement before operation and had confirmed postoperative pathology for
breast cancer from September 2016 to May 2019. According to the postoperative
pathology, the patients were divided into ALN-metastasis group(82) and non-ALN-metastasis
group(n=115),then the patients were randomly assigned to training group(n=131)
and verification group(n=66). A dedicated software (Philips radiomics tool) was
used to draw the contour of the tumors in the early phase and late phase
enhanced Silhouette images and calculate the features. A total of 3386 radiomic
features were extracted from each patient include tumor intensity statistics,
size and shape, intensity statistics, and texture feature using pyradiomics [3]. In the following
feature dimension reduction analysis, we used Spearman correlation analysis to
select the key features. In modeling stage, we investigated 5 classification
methods (including Passive Aggressive Classifier, Perceptron, Ridge Classifier,
SGD Classifier, Logistic Regression, Linear SVC) for training and prediction. We
use 5-fold cross validation results as the performance of a specific machine
learning classifier. We use ’accuracy’ as the optimization metric to select the
classifier. The model was trained on the training cohort and their performance
was evaluated on the cross-validation cohort using the area under ROC curve
(AUC).Results
25 radiomic features were select the key
features to predict ALN status, Including 20 features from early phase enhanced
images and 5 features from late phase enhanced images. Ridge Classifier was
found to produce the most accurate model on training dataset. The prediction
model displayed an AUC of 0.82 and 0.79 for predicting ALN status in the
training group and validation group, respectively.Conclusion
Our result shows that some radiomics features
have great potential to be an useful index in predicting ALN status, therefore
providing helps for the development of clinical treatment decisions for breast
cancer.Discussion
This study tried to predict the ALN
metastasis in patients with breast cancer by DCE-MRI radiomic characteristics,
and showed good predictive performance in the training group and validation
group, respectively (AUC 0.85 ,0.79). MSKCC Nomogram is a model to predict the
SLN status which developed by The Memorial Sloan-Kettering Cancer Center. It
based on some clinicopathological characteristics, such as tumor size, and
pathological type and age, the AUC was 0.754 [4]. Compared with MSKCC Normogram, The predictive efficiency of our
radiomic model is better, and as a non-invasive method, which can be carried
out before operation, and radiomic will have the potential to provide more
auxiliary information for clinical treatment.Acknowledgements
No acknowledgement found.References
1. Weigel MT, Dowsett M. Current and
emerging biomarkers in breast cancer: prognosis and prediction. Endocr Relat Cancer. 2010;17(4):R245-262.
2. DeSantis CE, Lin CC,
Mariotto AB, et al. Cancer treatment and survivorship statistics, 2014. CA Cancer J Clin. 2014;64(4):252-271.
3. van Griethuysen, J. J. M., Fedorov, A., Parmar, C., Hosny, A., Aucoin, N., Narayan, V., Beets-Tan, R. G. H., Fillon-Robin, J. C., Pieper, S., Aerts, H. J. W. L. (2017). Computational Radiomics System to Decode the Radiographic Phenotype. Cancer Research, 77(21), e104–e107.
4. Bevilacqua JL,
Kattan MW, Fey JV, Cody HS, 3rd, Borgen PI, Van Zee KJ. Doctor, what are my
chances of having a positive sentinel node? A validated nomogram for risk
estimation. J Clin Oncol. 2007;25(24):3670-3679.